The FDA has approved the registration of 2 tuberculosis medicines since 2021
Today (27 February 2023) Mr. Weerachai Nonlawachai Deputy Secretary-General of the Food and Drug Administration revealed that according to medical experts commenting on social media asking questions Why Thailand does not have a combination of 4 types of tuberculosis drugs in one pill, causing patients to take many pills per day .Approval of registration 2 combination regimens of tuberculosis treatment, Isoniazid + Rifampicin + Pyrazinamide + Ethambutol:
1) RIPE-900 (RIPE-900), drug registration number 2A 110/64, produced by Umeda Co., Ltd. (registration approved in 2021).
2) Foscos-Trac (FORECOX-TRAC), Pharmacy Registration Number 2C 13/65, Manufactured by MACLEODS PHARMACEUTICALS LIMITED, Republic of India, Imported by Atlanta Medicare Co., Ltd. (Registration Approved in 2022 )
Mr. Wirachai said that both of the above medicines It is a drug listed in the National List of Essential Medicines, List B, and is used to treat tuberculosis in the early stages and that there is information from the Tuberculosis Division, Department of Disease Control, to purchase combined tuberculosis drugs, trade names Rifampicin 150 mg, Isoniazid 75 mg, Pyrazinamide 400 mg & Ethambutol hydrochloride 275 mg Tablet USP using Global Fund 2023 purchases for the treatment of 2,000 patients.
“FDA confirms that Thailand has a combination drug regimen for treating tuberculosis. and the business operations of pharmaceutical companies that have been approved for registration, ”said Mr. Veerachai.
